Barclays’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $82.5K | Sell |
2,160
-16,629
| -89% | -$526K | ﹤0.01% | 4106 |
|
|
2025
Q4 | $410K | Buy |
18,789
+2,388
| +15% | +$49.6K | ﹤0.01% | 3957 |
|
|
2025
Q3 | $352K | Sell |
16,401
-8,411
| -34% | -$189K | ﹤0.01% | 3998 |
|
|
2025
Q2 | $636K | Sell |
24,812
-8,309
| -25% | -$243K | ﹤0.01% | 3619 |
|
|
2025
Q1 | $1.21M | Sell |
33,121
-4,904
| -13% | -$169K | ﹤0.01% | 2990 |
|
|
2024
Q4 | $1.17M | Buy |
38,025
+21,054
| +124% | +$700K | ﹤0.01% | 3278 |
|
|
2024
Q3 | $639K | Buy |
16,971
+12,484
| +278% | +$481K | ﹤0.01% | 3623 |
|
|
2024
Q2 | $178K | Sell |
4,487
-7,173
| -62% | -$232K | ﹤0.01% | 3635 |
|
|
2024
Q1 | $392K | Sell |
11,660
-8,670
| -43% | -$291K | ﹤0.01% | 3736 |
|
|
2023
Q4 | $677K | Buy |
20,330
+15,680
| +337% | +$506K | ﹤0.01% | 3696 |
|
|
2023
Q3 | $146K | Sell |
4,650
-1,597
| -26% | -$50.2K | ﹤0.01% | 3431 |
|
|
2023
Q2 | $198K | Sell |
6,247
-3,065
| -33% | -$99.1K | ﹤0.01% | 3244 |
|
|
2023
Q1 | $308K | Buy |
9,312
+4,368
| +88% | +$143K | ﹤0.01% | 3563 |
|
|
2022
Q4 | $159K | Buy |
4,944
+4,164
| +534% | +$142K | ﹤0.01% | 3973 |
|
|
2022
Q3 | $28K | Buy |
780
+171
| +28% | +$7.1K | ﹤0.01% | 3954 |
|
|
2022
Q2 | $25K | Sell |
609
-1,335
| -69% | -$64.8K | ﹤0.01% | 4303 |
|
|
2022
Q1 | $112K | Buy |
+1,944
| New | +$106K | ﹤0.01% | 3726 |
|
|
2019
Q3 | – | Sell |
-6,052
| Closed | -$284K | – | 6692 |
|
|
2019
Q2 | $284K | Buy |
6,052
+2,793
| +86% | +$118K | ﹤0.01% | 4802 |
|
|
2019
Q1 | $114K | Buy |
3,259
+2,987
| +1,098% | +$117K | ﹤0.01% | 5258 |
|
|
2018
Q4 | $10K | Sell |
272
-3,547
| -93% | -$139K | ﹤0.01% | 6158 |
|
|
2018
Q3 | $130K | Buy |
3,819
+2,882
| +308% | +$84.3K | ﹤0.01% | 5332 |
|
|
2018
Q2 | $23K | Sell |
937
-1,278
| -58% | -$35.6K | ﹤0.01% | 6095 |
|
|
2018
Q1 | $66K | Buy |
2,215
+678
| +44% | +$22.7K | ﹤0.01% | 5672 |
|
|
2017
Q4 | $49K | Buy |
1,537
+1,318
| +602% | +$42.4K | ﹤0.01% | 5769 |
|
|
2017
Q3 | $7K | Sell |
219
-25
| -10% | -$684 | ﹤0.01% | 6268 |
|
|
2017
Q2 | $6K | Buy |
244
+72
| +42% | +$1.67K | ﹤0.01% | 6177 |
|
|
2017
Q1 | $4K | Sell |
172
-231
| -57% | -$5.22K | ﹤0.01% | 6315 |
|
|
2016
Q4 | $9K | Buy |
403
+163
| +68% | +$3.93K | ﹤0.01% | 5924 |
|
|
2016
Q3 | $6K | Sell |
240
-257
| -52% | -$5.74K | ﹤0.01% | 5941 |
|
|
2016
Q2 | $11K | Buy |
+497
| New | +$15.7K | ﹤0.01% | 5492 |
|
|
2015
Q4 | – | Sell |
-68
| Closed | -$2K | – | 5976 |
|
|
2015
Q3 | $2K | Sell |
68
-180
| -73% | -$5.89K | ﹤0.01% | 6298 |
|
|
2015
Q2 | $10K | Buy |
+248
| New | +$11.7K | ﹤0.01% | 6071 |
|
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Barclays's ATEX Position: Q1 2026 in Review
Barclays reduced its Anterix (ATEX) stake by 89% in Q1 2026, selling an estimated $526K and leaving 2,160 shares worth $82.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4106.
Barclays first reported a position in ATEX in Q2 2015 and has held it in 32 quarters since. The position peaked at $1.21M in Q1 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Barclays held 2,160 shares of Anterix worth $82.5K as of Q1 2026.
- Barclays sold 16,629 Anterix shares in Q1 2026, an estimated $526K.
- Anterix made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4106 holding.
- Barclays first reported a position in Anterix in Q2 2015 and has held it in 32 quarters since.
- Barclays's Anterix position peaked at $1.21M in Q1 2025.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.